| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2176 | 1998 |
| Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ... The Lancet 383 (9935), 2127-2135, 2014 | 2028 | 2014 |
| A pooled analysis of bone marrow micrometastasis in breast cancer S Braun, FD Vogl, B Naume, W Janni, MP Osborne, RC Coombes, ... New England journal of medicine 353 (8), 793-802, 2005 | 1695 | 2005 |
| The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised … JS Haviland, JR Owen, JA Dewar, RK Agrawal, J Barrett, PJ Barrett-Lee, ... The lancet oncology 14 (11), 1086-1094, 2013 | 1675 | 2013 |
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (1001), 1341-1352, 2015 | 1413 | 2015 |
| The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial START Trialists' Group The Lancet 371 (9618), 1098-1107, 2008 | 1279 | 2008 |
| Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ... The Lancet 369 (9561), 559-570, 2007 | 1120 | 2007 |
| The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. SM Bentzen, RK Agrawal, EG Aird, JM Barrett, PJ Barrett-Lee, JM Bliss, ... The Lancet. Oncology 9 (4), 331-341, 2008 | 1114 | 2008 |
| Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen M Dowsett, J Cuzick, J Ingle, A Coates, J Forbes, J Bliss, M Buyse, ... Journal of Clinical Oncology 28 (3), 509-518, 2010 | 1083 | 2010 |
| Influence of psychological response on survival in breast cancer: a population-based cohort study M Watson, JS Haviland, S Greer, J Davidson, JM Bliss The Lancet 354 (9187), 1331-1336, 1999 | 1078 | 1999 |
| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 1032 | 2018 |
| Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial A Tutt, H Tovey, MCU Cheang, S Kernaghan, L Kilburn, P Gazinska, ... Nature medicine 24 (5), 628-637, 2018 | 931 | 2018 |
| The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. S Moorey, S Greer, M Watson, C Gorman, L Rowden, R Tunmore, ... The British Journal of Psychiatry 158 (2), 255-259, 1991 | 918 | 1991 |
| Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority … AM Brunt, JS Haviland, DA Wheatley, MA Sydenham, A Alhasso, ... The Lancet 395 (10237), 1613-1626, 2020 | 913 | 2020 |
| Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery … T Treasure, L Lang-Lazdunski, D Waller, JM Bliss, C Tan, J Entwisle, ... The lancet oncology 12 (8), 763-772, 2011 | 831 | 2011 |
| Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial JR Owen, A Ashton, JM Bliss, J Homewood, C Harper, J Hanson, ... The lancet oncology 7 (6), 467-471, 2006 | 790 | 2006 |
| Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer C Fribbens, B O’Leary, L Kilburn, S Hrebien, I Garcia-Murillas, M Beaney, ... Journal of Clinical Oncology 34 (25), 2961-2968, 2016 | 768 | 2016 |
| Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. S Greer, S Moorey, JD Baruch, M Watson, BM Robertson, A Mason, ... British Medical Journal 304 (6828), 675-680, 1992 | 755 | 1992 |
| Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials J Bergh, K Pritchard, K Albain, S Anderson, R Arriagada, W Barlow, ... The Lancet 386 (10001), 1353-1361, 2015 | 700 | 2015 |
| Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials EBCTC Group Lancet 386 (1001), 1353-1361, 2015 | 700 | 2015 |
